Yumanity Therapeutics and Proteostasis Therapeutics Announce Merger Agreement
Combined companies to leverage their common scientific expertise in protein misfolding
Focus on Yumanity's lead clinical program in Parkinson's disease and transformative pipeline of disease-modifying treatments for neurogenerative disorders
Companie... Biopharmaceuticals, Mergers & Acquisitions Proteostasis Therapeutics, Yumanity Therapeutics
Source: HSMN NewsFeed - Category: Pharmaceuticals Source Type: news
More News: Brain | Mergers and Aquisitions | Neurology | Neuroscience | Parkinson's Disease | Pharmaceuticals